Home › Mitral Valve Insufficiency › Minnesota
Mitral Valve Insufficiency clinical trials in Minnesota
9 studies for Mitral Valve Insufficiency are looking for participants at sites in Minnesota.
Cities in Minnesota
TVMR With the INNOVALVE System Trial - Early Feasibility Study
- Mayo Clinic, Rochester
Recruiting
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT04919980Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
- Abbott Northwestern Hospital, Minneapolis
Recruiting
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT03242642Cephea Early Feasibility Study
- Minneapolis Heart Institute, Minneapolis
Recruiting
Ages 18 and older · All sexes · Updated Sep 11, 2026 · NCT05061004Abbott Cephea Mitral Valve Disease Registry
- Minneapolis Heart Institute, Minneapolis
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 10, 2026 · NCT07069673ATLAS (AltaValve) Pivotal Trial
- Minneapolis Heart Institute Foundation, Minneapolis
- Mayo Clinic, Rochester
Recruiting
Ages 18 and older · All sexes · Updated Aug 3, 2026 · NCT06465745CHoice of OptImal transCatheter trEatment for Mitral Insufficiency Registry
- Minneapolis Heart Institute at Abbott Northwestern Hospital, Minneapolis
RecruitingObservational study
Ages 18 and older · All sexes · Updated May 7, 2026 · NCT04688190Transcatheter Mitral Valve Repair for Inotrope Dependent Cardiogenic Shock
- Mayo Clinic, Rochester
Recruiting
Ages 18 and older · All sexes · Updated May 6, 2026 · NCT05298124The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
- CentraCare Heart and Vascular, Saint Cloud
Recruiting
Ages 18 and older · All sexes · Updated Apr 13, 2026 · NCT03142152An Early Feasibility Study of the HighLife 28mm Trans-Septal Transcatheter Mitral Valve Replacement System
- Minneapolis Heart, Minneapolis
Recruiting
Ages 18 and older · All sexes · Updated Mar 17, 2025 · NCT04029337From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.